Skip to content

Effect of ayurvedic drug intervention in hypertension

EFFICACY OF SARPAGANDHA GHANA VATI ON ESSENTIAL HYPERTENSION â?? A RANDOMIZED CONTROLLED CLINICAL TRIAL - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038883
Enrollment
70
Registered
2021-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

KAHERS SHRI BMK AYURVEDA MAHAVIDYALAYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Criteria for the selection of the patients will be based on the criteria suggested by Joint National Committee 8 In patients aged less than 60 years with Systolic Blood Pressure greater than 140 mm Hg and Diastolic Blood Pressure greater than 90 mm Hg In patients aged more than 60 years with Systolic Blood pressure greater than 150 mm Hg and Diastolic Blood Pressure greater than 90 mm Hg Stages of Grade 1 Hypertension SBP 140 to 159 DBP 90 to 99mm Hg Patients between 20 to 70 years age of either sex

Exclusion criteria

Exclusion criteria: Ischemic heart disease Coronary heart disease Coronary artery disease and coarctation of aorta Renal failure Endocrine diseases, Hypertension with cerebral complications like hypertensive encephalopathy cerebral haemorrhage convulsive seizure Malignant hypertension Pregnant and Lactating female patients Patient on treatment for hypertension since 1 month

Design outcomes

Primary

MeasureTime frame
SUBJECTIVE PARAMETERS Primary Assessment Criteria Systolic blood pressure Diastolic blood pressure Secondary Assessment Criteria Mean arterial pressure Depression Anxiety Stress Scale long form DASS-42 Short Form 36 Quality of life 2 weeks sleep diary Pittsburgh Sleep Quality Index (PSQI)Timepoint: 0th day 15th day 30th day 45th day 60th day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactBASAVARAJ R TUBAKI

KAHERS SHRI BMK AYURVEDA MAHAVIDYALAYA

ayurbasavaraj@gmail.com9448634660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026